High levels of a protein known as CTRP9 appear to indicate worsening lung function in patients with systemic scleroderma…
Forest Ray PhD
Forest Ray received his PhD in systems biology from Columbia University, where he developed tools to match drug side effects to other diseases. He has since worked as a journalist and science writer, covering topics from rare diseases to the intersection between environmental science and social justice. He currently lives in Long Beach, California.
At Bionews we’re committed to providing the most accurate, relevant, and up-to-date reporting for our patient communities. Our goal is to ensure that everyone has access to disease-specific information that is both trustworthy and easy to understand. You can read more about our editorial policy here.
Articles by Forest Ray PhD
Changes from the norm in the electrical conduction of the heart — called cardiac axis deviations — are “common” and…
Scleroderma involving the lungs is associated with a greater degree of skin scarring, or fibrosis, according to a new research…
The amount of free light chain (FLC) molecules in blood and urine correspond to the severity of scleroderma, adding…
Mary J. Wheatley will succeed Robert J. Riggs as CEO of the Scleroderma Foundation, an organization dedicated to supporting…
People with weakened immune systems, such as those with scleroderma, should continue taking all COVID-19 precautions, even if fully…
Ofev (nintedanib) safely and effectively slowed lung function decline in people with interstitial lung disease (ILD) associated with systemic sclerosis…
The Scleroderma Foundation invites people to participate in Stepping Out to Cure Scleroderma, a combination of outdoor and virtual…
A computer algorithm called DETECT correctly identified all cases of a potentially life-threatening type of high blood pressure in a…
Treating facial atrophy in localized scleroderma by grafting stem cells from a patient’s own fat tissue appears to be…